Subclinical Thyroid Dysfunction and Fracture Risk: A Meta-analysis
Open accessAbstract
IMPORTANCE: Associations between subclinical thyroid dysfunction and fractures are unclear and clinical trials are lacking. OBJECTIVE: To assess the association of subclinical thyroid dysfunction with hip, nonspine, spine, or any fractures. DATA SOURCES AND STUDY SELECTION: The databases of MEDLINE and EMBASE (inception to March 26, 2015) were searched without language restrictions for prospective cohort studies with thyroid function data and subsequent fractures. DATA EXTRACTION: Individual participant data were obtained from 13 prospective cohorts in the United States, Europe, Australia, and Japan. Levels of thyroid function were defined as euthyroidism (thyroid-stimulating hormone [TSH], 0.45-4.49 mIU/L), subclinical hyperthyroidism (TSH <0.45 mIU/L), and subclinical hypothyroidism (TSH ≥4.50-19.99 mIU/L) with normal thyroxine concentrations. MAIN OUTCOME AND MEASURES: The primary outcome was hip fracture. Any fractures, nonspine fractures, and clinical spine fractures were secondary outcomes. RESULTS: Among 70,298 participants, 4092 (5.8%) had subclinical hypothyroidism and 2219 (3.2%) had subclinical hyperthyroidism. During 762,401 person-years of follow-up, hip fracture occurred in 2975 participants (4.6%; 12 studies), any fracture in 2528 participants (9.0%; 8 studies), nonspine fracture in 2018 participants (8.4%; 8 studies), and spine fracture in 296 participants (1.3%; 6 studies). In age- and sex-adjusted analyses, the hazard ratio (HR) for subclinical hyperthyroidism vs euthyroidism was 1.36 for hip fracture (95% CI, 1.13-1.64; 146 events in 2082 participants vs 2534 in 56,471); for any fracture, HR was 1.28 (95% CI, 1.06-1.53; 121 events in 888 participants vs 2203 in 25,901); for nonspine fracture, HR was 1.16 (95% CI, 0.95-1.41; 107 events in 946 participants vs 1745 in 21,722); and for spine fracture, HR was 1.51 (95% CI, 0.93-2.45; 17 events in 732 participants vs 255 in 20,328). Lower TSH was associated with higher fracture rates: for TSH of less than 0.10 mIU/L, HR was 1.61 for hip fracture (95% CI, 1.21-2.15; 47 events in 510 participants); for any fracture, HR was 1.98 (95% CI, 1.41-2.78; 44 events in 212 participants); for nonspine fracture, HR was 1.61 (95% CI, 0.96-2.71; 32 events in 185 participants); and for spine fracture, HR was 3.57 (95% CI, 1.88-6.78; 8 events in 162 participants). Risks were similar after adjustment for other fracture risk factors. Endogenous subclinical hyperthyroidism (excluding thyroid medication users) was associated with HRs of 1.52 (95% CI, 1.19-1.93) for hip fracture, 1.42 (95% CI, 1.16-1.74) for any fracture, and 1.74 (95% CI, 1.01-2.99) for spine fracture. No association was found between subclinical hypothyroidism and fracture risk. CONCLUSIONS AND RELEVANCE: Subclinical hyperthyroidism was associated with an increased risk of hip and other fractures, particularly among those with TSH levels of less than 0.10 mIU/L and those with endogenous subclinical hyperthyroidism. Further study is needed to determine whether treating subclinical hyperthyroidism can prevent fractures.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Data from available prospective cohort studies suggest an increased risk of hip fractures and non-spine fractures in SHyper, with the risk of fractures being greater in adults with grade 2 SHyper.
“Therefore, the data reported in the available prospective cohort studies suggest an increased risk of hip fractures and non-spine fractures in SHyper, with the risk of fractures being greater in adults with grade 2 SHyper [108, 109] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
The Results report increased hip-fracture risk with subclinical hyperthyroidism, and the Discussion says fracture risks were highest with suppressed TSH (<0.10 mIU/L), corresponding to grade 2 SHyper. But the Results report no statistically significant association for nonspine fractures overall and specifically say TSH below 0.10 mIU/L was not associated with increased nonspine-fracture risk. Page numbers were not provided in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measuredGrade 2 SHyper was associated with higher fracture rates.
“Grade 2 SHyper was associated with higher fracture rates with an HR of 1.61 (95% CI: 1.21-2.15;47 events in 510 participants) for hip fracture, 1.98 (95% CI: 1.41-2.78;44 events in 212 participants) for any fracture, 1.61 (95% CI: 0.96-2.71;32 events in 185 participants) for non-spine fracture and 3.57 (95% CI: 1.88-6.78;8 events in 162 participants) for spine fracture [109] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
The Abstract Results report the cited hazard ratios, confidence intervals, and event counts for participants with TSH below 0.10 mIU/L. However, the Results section explicitly says that this TSH group was not associated with increased nonspine fracture risk; its reported 95% CI includes 1. The sentence overstates the evidence if it presents all four fracture outcomes as associated with higher rates. (LLM, conf=0.88)
Experimental — accuracy not yet measuredThese meta-analyses demonstrate that SHyper is a potentially life-threatening condition.
“Although these meta-analyses do not show evidence that treatment is effective in improving the risks associated with untreated SHyper, they demonstrate that SHyper is a potentially life-threatening condition.”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
The Results section associates subclinical hyperthyroidism with increased hip and other fracture risks. The paper does not examine whether the condition causes death or conclude that it is potentially life-threatening, so that characterization goes beyond its findings. The Discussion also says there is no trial evidence that treatment reduces fracture risk. (LLM, conf=0.82)
Experimental — accuracy not yet measuredSubclinical hyperthyroidism is associated with low bone mineral density and an increased risk of fracture.
“Recent data, however, indicate that subclinical hyperthyroidism is associated with low bone mineral density (BMD) and an increased risk of fracture.”
From Thyroid diseases and bone health (2018) · cites this paper as [28]
The Discussion reports that subclinical hyperthyroidism was associated with increased hip and other fracture risk. It does not establish the claimed association with low BMD: the Discussion describes conflicting results from small trials examining treatment effects on BMD, while the introductory passage says subclinical thyroid dysfunction *could* be associated with bone loss. The supplied passages have no page numbers. (LLM, conf=0.88)
Experimental — accuracy not yet measuredSubclinical hyperthyroidism is associated with bone loss and fracture, particularly in individuals with endogenous disease.
“Overall, subclinical hyperthyroidism was associated with bone loss and fracture, particularly in individuals with endogenous disease [28].”
From Thyroid diseases and bone health (2018) · cites this paper as [28]
The Conclusions report increased fracture risk with subclinical hyperthyroidism, particularly in people with endogenous disease. The paper does not establish the claimed association with bone loss: its introduction says subclinical dysfunction could be associated with bone loss, and the Discussion describes bone loss as a possible mechanism rather than a measured outcome. (LLM, conf=0.87)
Experimental — accuracy not yet measured
There is much convincing evidence that asymptomatic endogenous hyperthyroidism adversely affects bones.
“Large-scale cohort studies and meta-analyses have reported an increased risk of osteoporosis and osteoporotic fractures, so there is much convincing evidence that asymptomatic endogenous hyperthyroidism adversely affects bones (14,39).”
From Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis (2021) · cites this paper as [39]
The Discussion reports an association between endogenous subclinical hyperthyroidism and increased fracture risk, and notes that symptoms may be absent. However, the paper does not establish that it causes bone damage or report an increased risk of osteoporosis specifically; its Conclusions remain framed as an association. No page number is available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe HR for hip fracture was 1.52 (95% CI 1.19-1.93).
“A very recent meta-analysis, including IPD from 13 prospective cohorts, confirmed that Endo SHyper is associated with an increased risk of fractures with an HR of 1.52 (95% CI: 1.19-1.93)for hip fracture, 1.42 (95% CI: 1.16-1.74)for any fracture and 1.74 (95% CI: 1.01-2.99)for spine fracture [109].”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
The HR for any fracture was 1.42 (95% CI 1.16-1.74).
“A very recent meta-analysis, including IPD from 13 prospective cohorts, confirmed that Endo SHyper is associated with an increased risk of fractures with an HR of 1.52 (95% CI: 1.19-1.93)for hip fracture, 1.42 (95% CI: 1.16-1.74)for any fracture and 1.74 (95% CI: 1.01-2.99)for spine fracture [109].”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
In grade 2 SHyper, the HR for spine fracture was 3.57 (95% CI 1.88-6.78; 8 events in 162 participants).
“Grade 2 SHyper was associated with higher fracture rates with an HR of 1.61 (95% CI: 1.21-2.15;47 events in 510 participants) for hip fracture, 1.98 (95% CI: 1.41-2.78;44 events in 212 participants) for any fracture, 1.61 (95% CI: 0.96-2.71;32 events in 185 participants) for non-spine fracture and 3.57 (95% CI: 1.88-6.78;8 events in 162 participants) for spine fracture [109] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
In grade 2 SHyper, the HR for hip fracture was 1.61 (95% CI 1.21-2.15; 47 events in 510 participants).
“Grade 2 SHyper was associated with higher fracture rates with an HR of 1.61 (95% CI: 1.21-2.15;47 events in 510 participants) for hip fracture, 1.98 (95% CI: 1.41-2.78;44 events in 212 participants) for any fracture, 1.61 (95% CI: 0.96-2.71;32 events in 185 participants) for non-spine fracture and 3.57 (95% CI: 1.88-6.78;8 events in 162 participants) for spine fracture [109] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
In grade 2 SHyper, the HR for non-spine fracture was 1.61 (95% CI 0.96-2.71; 32 events in 185 participants).
“Grade 2 SHyper was associated with higher fracture rates with an HR of 1.61 (95% CI: 1.21-2.15;47 events in 510 participants) for hip fracture, 1.98 (95% CI: 1.41-2.78;44 events in 212 participants) for any fracture, 1.61 (95% CI: 0.96-2.71;32 events in 185 participants) for non-spine fracture and 3.57 (95% CI: 1.88-6.78;8 events in 162 participants) for spine fracture [109] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
The HR for spine fracture was 1.74 (95% CI 1.01-2.99).
“A very recent meta-analysis, including IPD from 13 prospective cohorts, confirmed that Endo SHyper is associated with an increased risk of fractures with an HR of 1.52 (95% CI: 1.19-1.93)for hip fracture, 1.42 (95% CI: 1.16-1.74)for any fracture and 1.74 (95% CI: 1.01-2.99)for spine fracture [109].”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
In grade 2 SHyper, the HR for any fracture was 1.98 (95% CI 1.41-2.78; 44 events in 212 participants).
“Grade 2 SHyper was associated with higher fracture rates with an HR of 1.61 (95% CI: 1.21-2.15;47 events in 510 participants) for hip fracture, 1.98 (95% CI: 1.41-2.78;44 events in 212 participants) for any fracture, 1.61 (95% CI: 0.96-2.71;32 events in 185 participants) for non-spine fracture and 3.57 (95% CI: 1.88-6.78;8 events in 162 participants) for spine fracture [109] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
A recent meta-analysis including IPD from 13 prospective cohorts confirmed that Endo SHyper is associated with an increased risk of fractures.
“A very recent meta-analysis, including IPD from 13 prospective cohorts, confirmed that Endo SHyper is associated with an increased risk of fractures with an HR of 1.52 (95% CI: 1.19-1.93)for hip fracture, 1.42 (95% CI: 1.16-1.74)for any fracture and 1.74 (95% CI: 1.01-2.99)for spine fracture [109].”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
Three recent meta-analyses provide evidence, based also on IPD data, for treating SHyper with undetectable TSH because of an excess risk of total mortality, CHD mortality, HF, incident AF and fractures among adults with grade 2 SHyper.
“Three recent meta-analyses provide evidence, based also on IPD data, for treating SHyper with undetectable TSH because of an excess risk of total mortality, CHD mortality, HF, incident AF and fractures among adults with grade 2 SHyper [71,75,108,109] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
These meta-analyses do not show evidence that treatment is effective in improving the risks associated with untreated SHyper.
“Although these meta-analyses do not show evidence that treatment is effective in improving the risks associated with untreated SHyper, they demonstrate that SHyper is a potentially life-threatening condition.”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [109]
A recent participant-level meta-analysis of 13 cohorts (70,298 participants, median follow-up of 12.1 years) concluded that SH subjects had significantly elevated hazard ratios of 1.36 for hip fractures (6 vs. 4.9 fractures per 1000 person-years) and 1.28 for any fractures (14.4 vs. 11.2 fractures per 1000 person-years).
“A recent participant-level meta-analysis of 13 cohorts (70,298 participants, median follow-up of 12.1 years) con-cluded that SH subjects had significantly elevated hazard ratios of 1.36 for hip fractures (6 vs. 4.9 fractures per 1000 person-years) and 1.28 for any fractures (14.4 vs. 11.2fractures per 1000 person-years) (413).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [413]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823 · see citing works
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · see citing works
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · see citing works
(2014) · Medical Entomology and Zoology · Cited by 17,633 · see citing works
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · see citing works
Schafer, J. L. (1999) · Statistical Methods in Medical Research · doi:10.1177/096228029900800102 · Cited by 3,949 · see citing works
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652 · see citing works
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,312 · see citing works
Meta-analysis of individual participant data: rationale, conduct, and reporting
Riley, R. D., Lambert, P. C., & Abo-Zaid, G. (2010) · BMJ · doi:10.1136/bmj.c221 · Cited by 1,701 · see citing works
Systematic Reviews in Health Care: Meta‐analysis in Context
Pittler, M. (2010) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.2002.tb05479.x · Cited by 1,639 · see citing works
Body mass index as a predictor of fracture risk: A meta-analysis
De Laet, C., Kanis, J. A., Odén, A., Johanson, H., Johnell, O., Delmas, P., Eisman, J. A., Kroger, H., Fujiwara, S., Garnero, P., et al. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1863-y · Cited by 1,622 · see citing works
The Rotterdam Study: objectives and design update
Albert Hofman, D., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A. P., Stricker, B. H. C., Tiemeier, H. W., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,404 · see citing works
Self-citationSubclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1361 · Cited by 1,216 · see citing works
Self-citationBahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098 · see citing works
Smoking and fracture risk: a meta-analysis
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., De Laet, C., Eisman, J. A., Fujiwara, S., Kroger, H., McCloskey, E. V., Mellstrom, D., et al. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1640-3 · Cited by 999 · see citing works
Schafer, J. L. (1999) · Statistical Methods in Medical Research · doi:10.1191/096228099671525676 · Cited by 920 · see citing works
Thyroid Status, Disability and Cognitive Function, and Survival in Old Age
Gussekloo, J. (2004) · JAMA · doi:10.1001/jama.292.21.2591 · Cited by 899 · see citing works
Self-citationThe American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898 · see citing works
Nevitt, M. C., Ettinger, B., Black, D. M., Stone, K. L., Jamal, S. A., Ensrud, K. E., Segal, M. R., Genant, H. K., & Cummings, S. R. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-10-199805150-00001 · Cited by 841 · see citing works
Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models
Lyles, R. H. (2006) · Journal of the American Statistical Association · doi:10.1198/jasa.2006.s90 · Cited by 790 · see citing works
Systematic reviews of evaluations of prognostic variables
Altman, D. G. (2001) · BMJ · doi:10.1136/bmj.323.7306.224 · Cited by 751 · see citing works
Regression Methods in Biostatistics
Vittinghoff, E., Glidden, D. V., Shiboski, S. C., & McCulloch, C. E. (2012) · Statistics in the health sciences · doi:10.1007/978-1-4614-1353-0 · Cited by 666 · see citing works
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality
Collet, T.-H., Gussekloo, J., Bauer, D. C., den Elzen, W. P. J., Cappola, A. R., Balmer, P., Iervasi, G., Åsvold, B. O., Sgarbi, J. A., Völzke, H., et al. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.402 · Cited by 572 · see citing works
Self-citationFade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567 · see citing works
Simmonds, M. C., Higgins, J. P. T., Stewart, L. A., Tierney, J. F., Clarke, M. J., & Thompson, S. G. (2005) · Clinical Trials · doi:10.1191/1740774505cn087oa · Cited by 557 · see citing works
Subclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536 · see citing works
Self-citationGencer, B., Collet, T.-H., Virgini, V., Bauer, D. C., Gussekloo, J., Cappola, A. R., Nanchen, D., den Elzen, W. P. J., Balmer, P., Luben, R. N., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.096024 · Cited by 517 · see citing works
Self-citationSubclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death
Rodondi, N., Newman, A. B., Vittinghoff, E., de Rekeneire, N., Satterfield, S., Harris, T. B., & Bauer, D. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2460 · Cited by 503 · see citing works
Self-citationChi-squared goodness-of-fit tests for the proportional hazards regression model
Schoenfeld, D. (1980) · Biometrika · doi:10.1093/biomet/67.1.145 · Cited by 493 · see citing works
Risk for fracture in women with low serum levels of thyroid-stimulating hormone
Bauer, D. C., Ettinger, B., Nevitt, M. C., Stone, K. L., & for the Study of Osteoporotic Fractures Research Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00009 · Cited by 467 · see citing works
Self-citationFlynn, R. W., Bonellie, S. R., Jung, R. T., MacDonald, T. M., Morris, A. D., & Leese, G. P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1625 · Cited by 415 · see citing works
A Solution to the Problem of Monotone Likelihood in Cox Regression
Heinze, G., & SCHEMPER, M. (2001) · Biometrics · doi:10.1111/j.0006-341x.2001.00114.x · Cited by 397 · see citing works
Risk for Ischemic Heart Disease and All-Cause Mortality in Subclinical Hypothyroidism
Imaizumi, M., Akahoshi, M., Ichimaru, S., Nakashima, E., Hida, A., Soda, M., Usa, T., Ashizawa, K., Yokoyama, N., Maeda, R., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031089 · Cited by 373 · see citing works
Self-citationFink, H. A., Milavetz, D. L., Palermo, L., Nevitt, M. C., Cauley, J. A., Genant, H. K., Black, D. M., & Ensrud, K. E. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050314 · Cited by 365 · see citing works
Self-citationThe Rotterdam Study: 2014 objectives and design update
Albert Hofman, D., Murad, S. D., van Duijn, C. M., Franco, O. H., Goedegebure, A., Ikram, M. A., Klaver, C. C. W., Nijsten, T. E. C., Peeters, R. P., Stricker, B. H. C., et al. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9866-z · Cited by 330 · see citing works
Self-citationHyperthyroidism, Bone Mineral, and Fracture Risk—A Meta-Analysis
Vestergaard, P., & Mosekilde, L. (2003) · Thyroid · doi:10.1089/105072503322238854 · Cited by 306 · see citing works
Walsh, J. P., Bremner, A. P., Feddema, P., Leedman, P. J., Brown, S. J., & O'Leary, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1977 · Cited by 252 · see citing works
Self-citationThe Effect of Thyroid Hormone on Skeletal Integrity
Greenspan, S. L., & Greenspan, F. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-9-199905040-00016 · Cited by 249 · see citing works
Systematic reviews and meta-analyses of randomized trials: principles and pitfalls
da Costa, B. R., & Jüni, P. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu424 · Cited by 247 · see citing works
Self-citationMeyerovitch, J. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1533 · Cited by 245 · see citing works
Waring, A. C., Arnold, A. M., Newman, A. B., Bùžková, P., Hirsch, C., & Cappola, A. R. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2481 · Cited by 237 · see citing works
Self-citationTechniques for Handling Missing Data in Secondary Analyses of Large Surveys
Langkamp, D. L., Lehman, A., & Lemeshow, S. (2010) · Academic Pediatrics · doi:10.1016/j.acap.2010.01.005 · Cited by 218 · see citing works
Nanchen, D., Gussekloo, J., Westendorp, R. G. J., Stott, D. J., Jukema, J. W., Trompet, S., Ford, I., Welsh, P., Sattar, N., Macfarlane, P. W., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1978 · Cited by 211 · see citing works
Self-citationMurphy, E., Glüer, C. C., Reid, D. M., Felsenberg, D., Roux, C., Eastell, R., & Williams, G. R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2630 · Cited by 180 · see citing works
Self-citationBoekholdt, S. M., Titan, S. M., Wiersinga, W. M., Chatterjee, K., Basart, D. C. G., Luben, R., Wareham, N. J., & Khaw, K. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03640.x · Cited by 167 · see citing works
Self-citationRisk Factors for Low Bone Mass-Related Fractures in Men: A Systematic Review and Meta-Analysis
Drake, M. T., Murad, M. H., Mauck, K. F., Lane, M. A., Undavalli, C., Elraiyah, T. A., Stuart, L. M., Prasad, C., Shahrour, A., Mullan, R. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3058 · Cited by 165 · see citing works
The Impact of Overt and Subclinical Hyperthyroidism on Skeletal Muscle
Brennan, M. D., Powell, C., Kaufman, K. R., Sun, P. C., Bahn, R. S., & Nair, K. S. (2006) · Thyroid · doi:10.1089/thy.2006.16.375 · Cited by 155 · see citing works
Levothyroxine dose and risk of fractures in older adults: nested case-control study
Turner, M. R., Camacho, X., Fischer, H. D., Austin, P. C., Anderson, G. M., Rochon, P. A., & Lipscombe, L. L. (2011) · BMJ · doi:10.1136/bmj.d2238 · Cited by 152 · see citing works
The skeletal consequences of thyrotoxicosis
Nicholls, J. J., Brassill, M. J., Williams, G. R., & Bassett, J. H. D. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0059 · Cited by 138 · see citing works
Self-citationCritical role of the hypothalamic–pituitary–thyroid axis in bone
Bassett, J. H. D., & Williams, G. R. (2008) · Bone · doi:10.1016/j.bone.2008.05.007 · Cited by 137 · see citing works
Self-citationSubclinical Thyroid Dysfunction and Incident Hip Fracture in Older Adults
Lee, J. S., Bůžková, P., Fink, H. A., Vu, J., Carbone, L., Chen, Z., Cauley, J., Bauer, D. C., Cappola, A. R., & Robbins, J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.424 · Cited by 134 · see citing works
Self-citationBarrett-Connor, E. L., Weiss, T. W., McHorney, C. A., Miller, P. D., & Siris, E. S. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0748-2 · Cited by 129 · see citing works
Systematic Reviews of Evaluations of Prognostic Variables
Altman, D. G. (2001) · Wiley eBooks · doi:10.1002/9780470693926.ch13 · Cited by 123 · see citing works
Rosario, P. W. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03696.x · Cited by 88 · see citing works
Subclinical Thyroid Dysfunction and the Risk for Fractures: A Systematic Review and Meta-analysis
Wirth, C. D., Blum, M. R., da Costa, B. R., Baumgartner, C., Collet, T.-H., Medici, M., Peeters, R. P., Aujesky, D., Bauer, D. C., & Rodondi, N. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0125 · Cited by 85 · see citing works
Self-citationFinigan, J., Greenfield, D., Blumsohn, A., Hannon, R. A., Peel, N. F. A., Jiang, G., & Eastell, R. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070814 · Cited by 76 · see citing works
Self-citationCollet, T.-H., Bauer, D. C., Cappola, A. R., Åsvold, B. O., Weiler, S., Vittinghoff, E., Gussekloo, J., Bremner, A., den Elzen, W. P. J., Maciel, R. M. B., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1250 · Cited by 71 · see citing works
Self-citationA prospective study of thyroid function, bone loss, and fractures in older men: The MrOS study
Waring, A. C., Harrison, S., Fink, H. A., Samuels, M. H., Cawthon, P. M., Zmuda, J. M., Orwoll, E. S., Bauer, D. C., & Study, F. T. O. F. I. M. (. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1774 · Cited by 68 · see citing works
Self-citationCeresini, G., Ceda, G. P., Lauretani, F., Maggio, M., Usberti, E., Marina, M., Bandinelli, S., Guralnik, J. M., Valenti, G., & Ferrucci, L. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12267 · Cited by 67 · see citing works
Self-citationRoss, D. S. (1993) · American Journal of Medicine · doi:10.1016/0002-9343(93)90307-b · Cited by 59 · see citing works
Meier, C., Beat, M., Guglielmetti, M., Christ-Crain, M., Staub, J.-J., & Kraenzlin, M. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1527-8 · Cited by 55 · see citing works
Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway
Svare, A., Nilsen, T. I. L., Åsvold, B. O., Forsmo, S., Schei, B., Bjøro, T., & Langhammer, A. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0546 · Cited by 52 · see citing works
Self-citationThe Effect of Levothyroxine Therapy on Bone Mineral Density: A Systematic Review of the Literature
Schneider, R., & Reiners, C. (2004) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-44704 · Cited by 40 · see citing works
Buscemi, S., Verga, S., Cottone, S., Andronico, G., D’Orio, L., Mannino, V., Panzavecchia, D., Vitale, F., & Cerasola, G. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347430 · Cited by 35 · see citing works
Is Antithyroid Treatment Really Relevant for Young Patients with Subclinical Hyperthyroidism?
Yönem, Ö., Dökmetaş, H. S., Aslan, S. M., & Erselcan, T. (2002) · Endocrine Journal · doi:10.1507/endocrj.49.307 · Cited by 27 · see citing works
Meta-Analysis of Clinical Trials
Chen, D., & Peace, K. E. (2010) · CRC Press eBooks · doi:10.1201/b10478-14 · Cited by 25 · see citing works
Goichot, B., Sapin, R., & Schlienger, J. L. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.110627 · Cited by 22 · see citing works
Chi-Squared Goodness-of-Fit Tests for the Proportional Hazards Regression Model
Schoenfeld, D. (1980) · Biometrika · doi:10.2307/2335327 · Cited by 19 · see citing works
Schott, M. Ö. (2011) · Yearbook of Endocrinology · doi:10.1016/j.yend.2011.05.018 · Cited by 5 · see citing works
Principles in Developing and Applying Guidance
Helfand, M., & Balshem, H. (2009) · Cited by 4 · see citing works
Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis.
Wirth, C., Blum, M. R., da Costa, B. R., Baumgartner, C., Collet, T.-H., Medici, M., Peeters, R. P., Aujesky, D., Bauer, D. C., & Rodondi, N. (2014) · Open Access CRIS of the University of Bern · doi:10.7892/boris.62476 · Cited by 4 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [13]BMJ Clinical Evidence Search filters (Medline cohort study filter): ClinicalEvidence website 2013 http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665076.html Accessed May 5, 2015
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works
2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K. G., & Pearce, S. H. S. (2018) · European Thyroid Journal · doi:10.1159/000490384 · Cited by 982 · see citing works
Subclinical Hypothyroidism: A Review
Biondi, B., Cappola, A. R., & Cooper, D. S. (2019) · JAMA · doi:10.1001/jama.2019.9052 · Cited by 604 · see citing works
Self-citationRole of Thyroid Hormones in Skeletal Development and Bone Maintenance
Bassett, J. H. D., & Williams, G. R. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1106 · Cited by 540 · see citing works
Self-citationThe Rotterdam Study: 2018 update on objectives, design and main results
Ikram, M. A., Brusselle, G., Murad, S. D., van Duijn, C. M., Franco, O. H., Goedegebure, A., Klaver, C. C. W., Nijsten, T. E. C., Peeters, R. P., Stricker, B. H. C., et al. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0321-4 · Cited by 431 · see citing works
Self-citationThe Rotterdam Study: 2016 objectives and design update
Albert Hofman, D., Brusselle, G., Murad, S. D., van Duijn, C. M., Franco, O. H., Goedegebure, A., Ikram, M. A., Klaver, C. C. W., Nijsten, T. E. C., Peeters, R. P., et al. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0082-x · Cited by 382 · see citing works
Self-citationEbeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab028 · Cited by 354 · see citing works
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323 · see citing works
Lee, S. Y., & Pearce, E. N. (2023) · JAMA · doi:10.1001/jama.2023.19052 · Cited by 335 · see citing works
Thyroid diseases and bone health
Williams, G. R., & Bassett, J. H. D. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0753-4 · Cited by 276 · see citing works
Self-citationPeeters, R. P. (2017) · New England Journal of Medicine · doi:10.1056/nejmcp1611144 · Cited by 279 · see citing works
Self-citationCawthon, P. M., Manini, T., Patel, S. M., Newman, A., Travison, T., Kiel, D. P., Santanasto, A. J., Ensrud, K. E., Xue, Q., Shardell, M., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16517 · Cited by 231 · see citing works
Management of Graves Thyroidal and Extrathyroidal Disease: An Update
Kahaly, G. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa646 · Cited by 232 · see citing works
Thyroid Hormone Diseases and Osteoporosis
Delitala, A. P., Scuteri, A., & Doria, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041034 · Cited by 220 · see citing works
Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update
Floriani, C., Gencer, B., Collet, T., & Rodondi, N. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx050 · Cited by 154 · see citing works
Self-citationThyroid hormones in diabetes, cancer, and aging
Gauthier, B. R., Sola‐García, A., Cáliz‐Molina, M. Á., Lorenzo, P. I., Cobo‐Vuilleumier, N., Capilla‐González, V., & Martín‐Montalvo, A. (2020) · Aging Cell · doi:10.1111/acel.13260 · Cited by 147 · see citing works
Biondi, B., & Cooper, D. S. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1709318 · Cited by 135 · see citing works
Chaker, L., Cooper, D. S., Walsh, J. P., & Peeters, R. P. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02016-0 · Cited by 129 · see citing works
Self-citationThyroid hormone therapy for hypothyroidism
Biondi, B., & Cooper, D. S. (2019) · Endocrine · doi:10.1007/s12020-019-02023-7 · Cited by 110 · see citing works
Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study
Pearce, S. H. S., Razvi, S., Yadegarfar, M. E., Martin-Ruiz, C., Kingston, A., Collerton, J., Visser, T. J., Kirkwood, T. B., & Jagger, C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1935 · Cited by 91 · see citing works
Clinical aspects of thyroid function during ageing
Chaker, L., Cappola, A. R., Mooijaart, S. P., & Peeters, R. P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30028-7 · Cited by 94 · see citing works
Self-citationChaker, L., Baumgartner, C., den Elzen, W. P. J., Collet, T.-H., Ikram, M. A., Blum, M. R., Dehghan, A., Drechsler, C., Luben, R. N., Portegies, M. L. P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2255 · Cited by 92 · see citing works
Self-citationHormones and Aging: An Endocrine Society Scientific Statement
Cappola, A. R., Auchus, R. J., Fuleihan, G. E., Handelsman, D. J., Kalyani, R. R., McClung, M. R., Stuenkel, C. A., Thorner, M. O., & Verbalis, J. G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad225 · Cited by 102 · see citing works
Self-citationSegna, D., Bauer, D. C., Feller, M., Schneider, C., Fink, H. A., Aubert, C. E., Collet, T. ‐., da Costa, B. R., Fischer, K., Peeters, R. P., et al. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12688 · Cited by 87 · see citing works
Self-citationThyroid Hormone Suppression Therapy
Biondi, B., & Cooper, D. S. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.10.008 · Cited by 81 · see citing works
Valdés, S., Maldonado‐Araque, C., Lago-Sampedro, A. M., Lillo, J. A., García‐Fuentes, E., Perez‐Valero, V., Gutiérrez‐Repiso, C., Ocón, P., Goday, A., Urrutia, I., et al. (2016) · Thyroid · doi:10.1089/thy.2016.0353 · Cited by 78 · see citing works
Hormonal and systemic regulation of sclerostin
Drake, M. T., & Khosla, S. (2017) · Bone · doi:10.1016/j.bone.2016.12.004 · Cited by 77 · see citing works
McDermott, M. T. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202007070 · Cited by 79 · see citing works
Subclinical hypothyroidism in older individuals
Biondi, B., & Cappola, A. R. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00285-0 · Cited by 80 · see citing works
Self-citationThe Relation Between Thyroid Function and Anemia: A Pooled Analysis of Individual Participant Data
Wopereis, D. M., Puy, R. S. D., van Heemst, D., Walsh, J. P., Bremner, A., Bakker, S. J. L., Bauer, D. C., Cappola, A. R., Ceresini, G., Degryse, J., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00481 · Cited by 80 · see citing works
Self-citationRole of thyroid hormone therapy in depressive disorders
Bauer, M., & Whybrow, P. C. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01600-w · Cited by 72 · see citing works
Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?
Schneider, C., Feller, M., Bauer, D. C., Collet, T., da Costa, B. R., Auer, R., Peeters, R. P., Brown, S. J., Bremner, A., O'Leary, P. C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196631 · Cited by 72 · see citing works
Self-citationBano, A., Dhana, K., Chaker, L., Kavousi, M., Ikram, M. A., Mattace-Raso, F. U. S., Peeters, R. P., & Franco, O. H. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.4836 · Cited by 64 · see citing works
Self-citationRecent Advances in Autoimmune Thyroid Diseases
Yoo, W. S., & Chung, H. K. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.3.379 · Cited by 66 · see citing works
Bone quality in endocrine diseases: determinants and clinical relevance
Cianferotti, L., Cipriani, C., Corbetta, S., Corona, G., Defeudis, G., Lania, A. G., Messina, C., Napoli, N., & Mazziotti, G. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02056-w · Cited by 65 · see citing works
Blum, M. R., Wijsman, L. W., Virgini, V. S., Bauer, D. C., den Elzen, W. P. J., Jukema, J. W., Buckley, B. M., de Craen, A. J. M., Kearney, P. M., Stott, D. J., et al. (2015) · Neuroendocrinology · doi:10.1159/000437387 · Cited by 64 · see citing works
Self-citationSubclinical hypothyroidism: Should we treat?
Redford, C., & Vaidya, B. (2017) · Post Reproductive Health · doi:10.1177/2053369117705058 · Cited by 66 · see citing works
Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape
Yoo, W. S., & Chung, H. K. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1066 · Cited by 72 · see citing works
Sohn, S. Y., Lee, E., Lee, M. K., & Lee, J. H. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.728 · Cited by 60 · see citing works
Mazziotti, G., Formenti, A. M., Frara, S., Olivetti, R., Banfi, G., Memo, M., Maroldi, R., Giubbini, R., & Giustina, A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01986 · Cited by 57 · see citing works
The Influence of Thyroid Pathology on Osteoporosis and Fracture Risk: A Review
Apostu, D., Lucaciu, O., Oltean-Dan, D., Muresan, A., Moisescu-Pop, C., Maxim, A., & Benea, H. (2020) · Diagnostics · doi:10.3390/diagnostics10030149 · Cited by 55 · see citing works
Cakmak, S., Lukina, A. O., Karthikeyan, S., Atlas, E., & Dales, R. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.153900 · Cited by 58 · see citing works
Ku, E. J., Yoo, W. S., Lee, E. K., Ahn, H. Y., Woo, S. H., Hong, J. H., Chung, H. K., & Park, J.-W. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab539 · Cited by 57 · see citing works
Lang, X., Hou, X., Shangguan, F., & Zhang, X. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.004 · Cited by 55 · see citing works
Urgatz, B., & Razvi, S. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2165811 · Cited by 65 · see citing works
Aubert, C. E., Floriani, C., Bauer, D. C., da Costa, B. R., Segna, D., Blum, M. R., Collet, T., Fink, H. A., Cappola, A. R., Syrogiannouli, L., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00294 · Cited by 54 · see citing works
Self-citationEndocrine Regulation on Bone by Thyroid
Zhu, S., Pang, Y., Xu, J., Chen, X., Zhang, C., Wu, B. Y., & Gao, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873820 · Cited by 53 · see citing works
Yamada, S., Horiguchi, K., Akuzawa, M., Sakamaki, K., Yamada, E., Ozawa, A., Kobayashi, I., Shimomura, Y., Okamoto, Y., Andou, T., et al. (2023) · Thyroid · doi:10.1089/thy.2022.0567 · Cited by 51 · see citing works
Carlé, A., Andersen, S. L., Boelaert, K., & Laurberg, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0276 · Cited by 48 · see citing works
Stott, D. J., Gussekloo, J., Kearney, P. M., Rodondi, N., Westendorp, R. G. J., Mooijaart, S. P., Kean, S., Quinn, T. J., Sattar, N. A., Hendry, K., et al. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0156-8 · Cited by 47 · see citing works
Self-citationDiabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes
Ala, M., Jafari, R. M., & Dehpour, A. R. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200324152517 · Cited by 47 · see citing works
Pan, K. S., Heiss, J. D., Brown, S. M., Collins, M. T., & Boyce, A. M. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3531 · Cited by 45 · see citing works
Subclinical Hyperthyroidism: A Review of the Clinical Literature
Tsai, K., & Leung, A. M. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.02.002 · Cited by 45 · see citing works
Moon, J. H., Kim, K. M., Oh, T. J., Choi, S. H., Lim, S. K., Park, Y. J., Park, D. J., & Jang, H. C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2740 · Cited by 44 · see citing works
The ageing thyroid: implications for longevity and patient care
van Heemst, D. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00911-7 · Cited by 43 · see citing works
Prevalence, risks, and comorbidity of thyroid dysfunction: a cross-sectional epidemiological study
Rashad, N. M., & Samir, G. M. (2019) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_22_19 · Cited by 45 · see citing works
Hoff, M., Meyer, H. E., Skurtveit, S. O., Langhammer, A., Søgaard, A. J., Syversen, U., Dhainaut, A., Skovlund, E., Abrahamsen, B., & Schei, B. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4134-9 · Cited by 43 · see citing works
Self-citationEpidemiology of thyroid disorders in the Lifelines Cohort Study (the Netherlands)
Wouters, H. J. C. M., Slagter, S. N., Kobold, A. C. M., van der Klauw, M. M., & Wolffenbuttel, B. H. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242795 · Cited by 42 · see citing works
Thyrotropin, Hyperthyroidism, and Bone Mass
Kim, S., Ryu, V., Miyashita, S., Korkmaz, F., Lizneva, D., Gera, S., Latif, R., Davies, T. F., Iqbal, J. Z., Yuen, T., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab548 · Cited by 42 · see citing works
Thyroid Dysfunction and Anemia: A Prospective Cohort Study and a Systematic Review
Floriani, C., Feller, M., Aubert, C. E., M'Rabet‐Bensalah, K., Collet, T., den Elzen, W. P. J., Bauer, D. C., Angelillo‐Scherrer, A., Aujesky, D., & Rodondi, N. (2018) · Thyroid · doi:10.1089/thy.2017.0480 · Cited by 40 · see citing works
Self-citationUpdate on subclinical thyroid dysfunction
Hashimoto, K. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0182 · Cited by 44 · see citing works
TSH suppressive therapy and bone
Brancatella, A., & Marcocci, C. (2020) · Endocrine Connections · doi:10.1530/ec-20-0167 · Cited by 40 · see citing works
Hyperthyroidism Prevalence in China After Universal Salt Iodization
Wang, C., Li, Y., Teng, D., Shi, X., Ba, J., Chen, B., Du, J., He, L., Lai, X., Li, Y., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651534 · Cited by 40 · see citing works
Pituitary crosstalk with bone, adipose tissue and brain
Zaidi, M., Yuen, T., & Kim, S. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00894-5 · Cited by 44 · see citing works
Siru, R., Alfonso, H. S., Chubb, S. A. P., Golledge, J., Flicker, L. A., & Yeap, B. B. (2018) · Clinical Endocrinology · doi:10.1111/cen.13615 · Cited by 39 · see citing works
Fracture risk and assessment in adults with cancer
Ye, C., & Leslie, W. D. (2022) · Osteoporosis International · doi:10.1007/s00198-022-06631-4 · Cited by 37 · see citing works
Berglund, J. A., Tella, S. H., Tuthill, K. F., Kim, L., Guthrie, L. C., Paul, S. M., Stanton, R. P., Collins, M. T., & Boyce, A. M. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3446 · Cited by 37 · see citing works
Understanding and managing secondary osteoporosis
Colangelo, L., Biamonte, F., Pepe, J., Cipriani, C., & Minisola, S. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1575727 · Cited by 36 · see citing works
Palacios, S. S., Llavero-Valero, M., Brugos‐Larumbe, A., Díez, J. J., Guillén‐Grima, F., & Galofré, J. C. (2018) · Clinical Endocrinology · doi:10.1111/cen.13764 · Cited by 35 · see citing works
Kwak, D., Ha, J., Won, Y., Kwon, Y., & Park, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043007 · Cited by 34 · see citing works
Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal
Van Tassell, B., Wohlford, G. F., Linderman, J. D., Smith, S., Yavuz, S., Pucino, F., & Celi, F. S. (2019) · Thyroid® · doi:10.1089/thy.2019.0101 · Cited by 31 · see citing works
van Vliet, N. A., Noordam, R., van Klinken, J. B., Westendorp, R. G., Bassett, J. H. D., Williams, G. R., & van Heemst, D. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3426 · Cited by 33 · see citing works
Self-citationWildisen, L., Giovane, C. D., Moutzouri, E., Beglinger, S., Syrogiannouli, L., Collet, T., Cappola, A. R., Åsvold, B. O., Bakker, S. J. L., Yeap, B. B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75776-1 · Cited by 33 · see citing works
Self-citationExpert consensus on diagnosis and treatment for elderly with thyroid diseases in China (2021)
Liu, Y., Shan, Z., & Endocrine Metabolic Diseases Group of the Chinese Geriatrics Society (2021) · Aging Medicine · doi:10.1002/agm2.12165 · Cited by 33 · see citing works
10-Year Fracture Risk in Postmenopausal Women with Osteopenia and Osteoporosis in South Korea
Baek, Y., Cho, S. W., Jeong, H. E., Kim, J. H., Hwang, Y., Lange, J. L., & Shin, J. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1215 · Cited by 35 · see citing works
Ding, B., Zhang, Y., Li, Q., Hu, Y., Tao, X.-J., Liu, B.-L., Ma, J., & Li, D. M. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.07.009 · Cited by 32 · see citing works
Shin, D. W., Suh, B., Lim, H., Yun, J. M., Song, S. O., & Park, Y. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3407 · Cited by 32 · see citing works
Psoriasis, fracture risk and bone mineral density: the HUNT Study, Norway
Modalsli, E. H., Åsvold, B. O., Romundstad, P., Langhammer, A., Hoff, M., Forsmo, S., Naldi, L., & Saunes, M. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15123 · Cited by 32 · see citing works
Self-citationJasim, S., & Gharib, H. (2017) · Endocrine Practice · doi:10.4158/ep171796.ra · Cited by 35 · see citing works
Moon, J. H., Jung, K. Y., Kim, K. M., Choi, S. H., Lim, S. K., Park, Y. J., Park, D. J., & Jang, H. C. (2015) · Bone · doi:10.1016/j.bone.2015.10.015 · Cited by 31 · see citing works
Liu, C., Hua, L., Liu, K., & Zhong, X. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02035-1 · Cited by 30 · see citing works
Deng, T., Zhang, W., Zhang, Y., Zhang, M., Huan, Z., Yu, C., Zhang, X., Wang, Y., & Xu, J. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00715-8 · Cited by 32 · see citing works
Hill, M., Třískala, Z., Honců, P., Krejčí, M., Kajzar, J., Bičı́ková, M., Ondřejíková, L., Jandová, D., & Sterzl, I. (2020) · Physiological Research · doi:10.33549/physiolres.934523 · Cited by 31 · see citing works
Heterogeneity and Dynamics of Vasculature in the Endocrine System During Aging and Disease
Stücker, S., Angelis, J. E. D., & Kusumbe, A. P. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.624928 · Cited by 32 · see citing works
Yeap, B. B., Manning, L. A., Chubb, S. A. P., Hankey, G. J., Golledge, J., Almeida, O. P., & Flicker, L. A. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw132 · Cited by 28 · see citing works
Association between oral health and thyroid disorders: A population‐based cross‐sectional study
Kwon, M., Jeong, Y., Kwak, J., Jung, K., & Baek, S. (2021) · Oral Diseases · doi:10.1111/odi.13895 · Cited by 28 · see citing works
Gonzalez Rodriguez, E., Stuber, M., Del Giovane, C., Feller, M., Collet, T.-H., Löwe, A. L., Blum, M. R., van Vliet, N. A., van Heemst, D., Kearney, P. M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz058 · Cited by 33 · see citing works
Self-citationOsteoporose – Definition, Risikoerfassung, Diagnose, Prävention und Therapie (Update 2024)
Dimai, H. P., Muschitz, C., Amrein, K., Bauer, R., Cejka, D., Gasser, R. W., Gruber, R., Haschka, J., Hasenoehrl, T., Kainberger, F. M., et al. (2024) · Wiener klinische Wochenschrift · doi:10.1007/s00508-024-02441-2 · Cited by 27 · see citing works
Lin, W., Chen, W., Wang, P., Chan, Y., Chang, Y., Chen, H.-S., Chen, S., Chen, W., Cheng, K., Chi, S., et al. (2022) · ULTRASONOGRAPHY · doi:10.14366/usg.22126 · Cited by 28 · see citing works
Wang, Y., Wen, G., Zhou, R., Zhong, W., Lu, S., Hu, C., & Chai, Y. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00408 · Cited by 27 · see citing works
Proton pump inhibitors and fracture risk. The HUNT study, Norway
Hoff, M., Skovlund, E., Skurtveit, S. O., Meyer, H. E., Langhammer, A., Søgaard, A. J., Syversen, U., Forsmo, S., Abrahamsen, B., & Schei, B. (2019) · Osteoporosis International · doi:10.1007/s00198-019-05206-0 · Cited by 27 · see citing works
Self-citationZhu, H., Zhang, J., Wang, J., Zhao, X., & Gu, M. (2020) · Endocrine · doi:10.1007/s12020-019-02110-9 · Cited by 28 · see citing works
Alwan, H., Villoz, F., Feller, M., Dullaart, R. P. F., Bakker, S. J. L., Peeters, R. P., Kavousi, M., Bauer, D. C., Cappola, A. R., Yeap, B. B., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0523 · Cited by 25 · see citing works
Self-citationTsourdi, E. A., Lademann, F., Ominsky, M. S., Rijntjes, E., Köhrle, J., Misof, B. M., Roschger, P., Klaushofer, K., Hofbauer, L. C., & Rauner, M. (2017) · Endocrinology · doi:10.1210/en.2017-00247 · Cited by 25 · see citing works
The impact of thyroid autoimmunity (TPOAb) on bone density and fracture risk in postmenopausal women
Polovina, S. P., Miljić, D., Zivojinović, S., Milic, N. M., Micić, D., & Popović-Brkić, V. (2017) · HORMONES · doi:10.14310/horm.2002.1719 · Cited by 25 · see citing works
Lee, K., Lim, S., Park, H. H., Woo, H., Chang, Y., Sung, E., Jung, H. S., Yun, K. E., Kim, C., Ryu, S., et al. (2019) · Osteoporosis International · doi:10.1007/s00198-019-05205-1 · Cited by 26 · see citing works
Geels, R. E. S., Meier, M. E., Saikali, A., Tsonaka, R., Appelman‐Dijkstra, N. M., & Boyce, A. M. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4463 · Cited by 24 · see citing works
How does Hashimoto’s thyroiditis affect bone metabolism?
Wu, J., Huang, H., & Yu, X. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09778-x · Cited by 24 · see citing works
Hennessey, J. V., Garber, J. R., Woeber, K. A., Cobin, R. H., & Klein, I. L. (2016) · Endocrine Practice · doi:10.4158/ep151038.ps · Cited by 24 · see citing works
Lamartina, L., Montesano, T., Falcone, R., Biffoni, M., Grani, G., Maranghi, M., Ciotti, L., Giacomelli, L., Ramundo, V., Lomonaco, C., et al. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0393 · Cited by 23 · see citing works
- Authors
- Blum, M. R., Bauer, D. C., Collet, T.-H., Fink, H. A., Cappola, A. R., da Costa, B. R., Wirth, C. D., Peeters, R. P., Åsvold, B. O., den Elzen, W. P. J., Luben, R. N., Imaizumi, M., Bremner, A. P., Gogakos, A., Eastell, R., Kearney, P. M., Strotmeyer, E. S., Wallace, E. R., Hoff, M., Ceresini, G., Rivadeneira, F., Uitterlinden, A. G., Stott, D. J., Westendorp, R. G. J., Khaw, K.-T., Langhammer, A., Ferrucci, L., Gussekloo, J., Williams, G. R., Walsh, J. P., Jüni, P., Aujesky, D., & Rodondi, N.
- Affiliations
- University Hospital of Bern (CH)
- University of California, San Francisco (US)
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Minnesota (US)
- University of Pennsylvania Health System (US)
- Department of Physical Therapy, Nicole Wertheim College of Nursing and Health Science, Florida International University, Miami
- Erasmus MC (NL)
- Norwegian University of Science and Technology (NO)
- Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands
- University of Cambridge (GB)
- Radiation Effects Research Foundation (JP)
- The University of Western Australia (AU)
- Imperial College London (GB)
- University of Sheffield (GB)
- University College Cork (IE)
- University of Pittsburgh (US)
- University of Washington (US)
- Ospedale di Parma (IT)
- University of Glasgow (GB)
- University of Copenhagen (DK)
- National Institutes of Health (US)
- Leiden University Medical Center (NL)
- University of Bern (CH)
- Corresponding author
- Rodondi, Nicolas
- ORCID
- Blum, Manuel R.
- Bauer, Douglas C.
- Collet, Tinh-Hai
- Fink, Howard A.
- Cappola, Anne R.
- Wirth, Christina D.
- Peeters, Robin P.
- Åsvold, Bjørn O.
- Luben, Robert N.
- Bremner, Alexandra P.
- Gogakos, Apostolos
- Eastell, Richard
- Kearney, Patricia M.
- Strotmeyer, Elsa S.
- Wallace, Erin R.
- Hoff, Mari
- Ceresini, Graziano
- Rivadeneira, Fernando
- Uitterlinden, André G.
- Stott, David J.
- Westendorp, Rudi G. J.
- Khaw, Kay-Tee
- Ferrucci, Luigi
- Gussekloo, Jacobijn
- Williams, Graham R.
- Walsh, John P.
- Jüni, Peter
- Aujesky, Drahomir
- Rodondi, Nicolas
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-05-26
- Volume
- 313
- Issue
- 20
- Pages
- 2055
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC4729304
- OpenAlex
- W1651572921
- Cited by
- 343
- References
- 71
- Citations by year
- 2026: 25 · 2025: 27 · 2024: 22 · 2023: 28 · 2022: 37 · 2021: 42 · 2020: 45 · 2019: 22 · 2018: 37 · 2017: 23 · 2016: 24 · 2015: 11
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- PubMed Central (acceptedVersion)
- SERVAL (Université de Lausanne) (acceptedVersion, other-oa)
- IRIS (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Open Access CRIS of the University of Bern
- Funders
- National Science Foundation
- American Heart Association
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Alexion Pharmaceuticals
- Alere
- University of Pittsburgh
- Norges Teknisk-Naturvitenskapelige Universitet
- Radius Health
- Cancer Research UK
- National Institute for Health and Care Research (NF-SI-0512-10114, UL1TR000128, NF-SI-0513-10073)
- National Osteoporosis Society
- European Commission
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320 030-150 025, 150025, 138267, 145870, 320030, 155318)
- ZonMw
- Fonterra Co-Operative Group
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (911-03-016)
- Schweizerische Herzstiftung
- International Osteoporosis Foundation
- National Institutes of Health (N01-AG-6-2103, n01hc085082-026, n01hc085081-021, n01hc085079-024, UL1TR000128, n01hc085083-027, n01hc085080-026, N01‐AG‐6‐2106, n01hc085086-022, HHSN268200800007C, N01-AG-6-2101, HHSN268201200036C, n01hc055222-001, N01HC85086, N01-HC-85082, N01HC85079, N01HC85080, N01HC85083, N01-HC-85081)
- Canadian Institutes of Health Research
- Medical Research Council (MR/K006312/1)
- Norwegian Institute of Public Health
- National Institute on Aging (N01‐AG‐6–2101, N01HC85081, N01HC85079, U01AG042145, N01-HC-85080, N01-HC-85082, U01AG042168, R01AG028050, N01HC55222, HHSN268200800007C, U01AG042143, U01AG027810, N01-HC-85083, U01AG042139, N01AG62106, U01AG042124, N01HC85083, N01HC85086, U01AG042140, N01‐HC‐85086, R01AG023629, N01-AG-62103, HHSN268201200036C)
- National Heart, Lung, and Blood Institute (N01-HC-85081, N01 HC085086, N01HC-85083, N01 HC085079, N01 HC085083, N01HC85082, N01 HC85086, HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01 HC085080, HHSN 268200800007C, N01HC85080, N01AG62101, N01 HC55222, N01AG62106, HHSN268201200036C, N01HC085082, U01HL080295, N01 HC055222, N01AG62103, N01 HC085081, N01-HC85079)
- National Institute of Nursing Research (N01-AG-6–2101, N01-AG-6-2103, N01-AG-6–2106, R01NR012459)
- National Institute of Neurological Disorders and Stroke (N01-AG-6-2106, N01-AG-6-2103, HHSN268200800007C, N01-HC-85080, N01-HC-85083, N01HC85082, N01-AG-6-2101, N01-HC-85081, N01-HC-85086, N01 HC-55222, N01HC85079, HHSN268201200036C)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (U01AR066160, K24AR051895)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- subclinical thyroid dysfunction, subclinical hyperthyroidism, subclinical hypothyroidism, hip fracture, fracture risk, thyroid-stimulating hormone, spinal fractures, fracture risk factors, bone health, osteoporosis, vitamin D, calcium intake, physical activity, sex differences, age differences, individual patient data meta-analysis, prospective cohort
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Hip Fractures, Humans, Hyperthyroidism, Hypothyroidism, Male, Middle Aged, Risk Factors, Thyrotropin, Spinal Fractures, Fractures, Bone, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
